Erythromelalgia Caused by Polycythemia Vera Combined with Primary Aldosteronism.

Erythromelalgia polycythemia vera primary aldosteronism

Journal

European journal of case reports in internal medicine
ISSN: 2284-2594
Titre abrégé: Eur J Case Rep Intern Med
Pays: Italy
ID NLM: 101648453

Informations de publication

Date de publication:
2020
Historique:
received: 29 06 2020
accepted: 13 07 2020
entrez: 16 11 2020
pubmed: 17 11 2020
medline: 17 11 2020
Statut: epublish

Résumé

A 61-year-old woman with a history of primary aldosteronism caused by unilateral hyperplasia of the adrenal gland presented with a 2-week history of redness and severe pain in the right thumb and thenar regions. She had initially visited a dermatologist and was diagnosed with cellulitis and treated with cefditoren pivoxil for 5 days, but there was no improvement. The pain worsened and was accompanied by a burning sensation. The dermatologist prescribed famciclovir for 5 days owing to suspicion of herpes zoster. The patient was then referred to our department because her symptoms persisted. Physical examination showed no abnormalities other than the redness in the right thumb and thenar regions and spontaneous moderate pain present throughout the right thumb. Investigations revealed normal blood chemistry and coagulation factor levels, except for elevated haemoglobin (18.2 g/dl). Further investigations revealed an erythropoietin level of 2.3 IU/ml and Janus kinase 2 mutation. Hence, we diagnosed the patient with erythromelalgia caused by polycythemia vera. In this report, we discuss the treatment of polycythemia causing erythromelalgia, and the aetiology of primary aldosteronism and polycythemia vera. Polycythemia can cause erythromelalgia, which should be treated with aspirin.Primary aldosteronism causes secondary erythropoiesis through activation of the renin-aldosterone system, but the mechanism is not clear.Erythropoiesis may be promoted by concurrent primary aldosteronism and polycythemia vera, resulting in secondary erythromelalgia.

Identifiants

pubmed: 33194862
doi: 10.12890/2020_001852
pii: 1852-1-15724-1-10-20200810
pmc: PMC7654995
doi:

Types de publication

Journal Article

Langues

eng

Pagination

001852

Informations de copyright

© EFIM 2020.

Déclaration de conflit d'intérêts

Conflicts of Interests: The Authors declare that there are no competing interests.

Références

J Am Acad Dermatol. 2000 Nov;43(5 Pt 1):841-7
pubmed: 11050591
FASEB J. 2005 Dec;19(14):2023-5
pubmed: 16223784
Cancer Biol Ther. 2007 Sep;6(9):1434-6
pubmed: 17873518
Nature. 1995 May 18;375(6528):247-50
pubmed: 7746328
Am J Hematol. 2012 Mar;87(3):285-93
pubmed: 22331582

Auteurs

Morika Suzuki (M)

Department of General Internal Medicine, National Hospital Organization Sendai Medical Center, Miyagi, Japan.

Takashi Watari (T)

Postgraduate Clinical Training Centre, Shimane University Hospital, Shimane, Japan.

Classifications MeSH